Pharmacoeconomic Analysis of Cardiovascular Treatments in Romania - Original Vs. Generic Drugs

Abstract

Pharmacoeconomic evaluations serve as pivotal tools in healthcare decision-making, particularly in the realm of cardiovascular treatments where efficacy, safety, and cost considerations intersect. This article presents a comprehensive analysis comparing the pharmacoeconomic profiles of original and generic drugs in cardiovascular care. The article delves into the intricate interplay of pricing dynamics, market competition, and regulatory policies shaping the accessibility and affordability of original and generic cardiovascular medications. Moreover, through case studies and comparative effectiveness research, the article provides insights into the real-world utilization patterns and economic outcomes associated with the adoption of generic cardiovascular drugs within clinical practice settings. It highlights the potential cost savings, budgetary implications, and patient outcomes stemming from the utilization of generic medications, while also acknowledging the importance of ensuring therapeutic continuity and medication adherence.